Pilot Ipilimumab in Stage IV Melanoma Receiving Palliative Radiation Therapy

This study hopes to determine the effect of a combination of docetaxel, cisplatin, and cetuximab in weekly treatment of squamous cell carcinoma of the head and neck. The study would like to determine if giving the combination of these drugs at lower, more frequent doses will result in less severe side effects and be an effective anti-cancer treatment.

Principal Investigator

Stanford Investigator(s)


Primary Contact:
Chuck Di Bari
(650) 498-4073